Investec has advised the shareholders of Interchemie on the sale to Nimbus
About the deal
Investec has advised the shareholders of Interchemie on the sale to Nimbus, a Dutch hands-on private equity firm. The firm manufactures a broad portfolio of veterinary products, including veterinary medicines, nutritional products, and feed additives internationally.
This transaction underscores Investec’s strong track record in the global animal health sector and further highlights our established expertise, supported by a dedicated team with deep experience in sector transactions.
About Interchemie
Interchemie was founded in 1979 and is headquartered in Waalre, the Netherlands. Interchemie develops and produces a broad portfolio of generic veterinary products in line with European GMP and GMP+ standards across three production facilities in the Netherlands, Estonia & Lithuania.
Interchemie has grown into a leading global player in animal health through a network of around >135 exclusive distributors worldwide. The company holds particularly strong positions in Africa and the Middle East, where its brand and distribution network are well-established.
About Nimbus
Nimbus focuses on medium-sized European businesses in industrial, manufacturing, and technical trade sectors and has completed more than 120 investments since its founding in 1993.
Nimbus will continue to work closely with Interchemie’s management team to accelerate internationalisation, broaden the product portfolio, and scale operations in line with the increasing global demand for accessible veterinary health solutions.
Our role
Investec advised the shareholders of Interchemie throughout the sale, including:
- Drafting information and marketing materials
- Managing price negotiations
- Handling due diligence
- Coordinating the legal documentation phase
